Angiodynamics Inc. (Navilyst Medical Inc.) recalls RS 5F DL XCELA PICC, Catalog Number 60M122272
- Recall date
- May 10, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2225-2018
- FDA classification
- Class II
- Brand / firm
- Angiodynamics Inc. (Navilyst Medical Inc.)
- Sold / distributed
- The products were distributed to the following US states: AZ, CA, CO, CT, DC, FL, GA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, WA, WI, and WV. The products were distributed to the following foreign countries: Canada, China, Ireland, Spain.
Why it was recalled
A component of the kits might contain unsafe levels of bacterial endotoxins (pyrogens).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
RS 5F DL XCELA PICC, Catalog Number 60M122272
Get recall alerts
Free email alert whenever Angiodynamics Inc. (Navilyst Medical Inc.) has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Angiodynamics Inc. (Navilyst Medical Inc.)